SCHEMBL27618693

SCHEMBL27618693

O=C(c1ccccc1)N1CCN(CCc2c[nH]c3c(-n4cccn4)ccnc23)CC1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
KCNH2 Q12809 1/20 0.46
LMNA P02545 1/20 0.42
KCNA5 P22460 3/20 0.41
SIGMAR1 Q99720 1/20 0.41
DRD2 P14416 3/20 0.41
DRD3 P35462 2/20 0.41
KDM4E B2RXH2 2/20 0.40
THRB P10828 1/20 0.39
HTR2A P28223 2/20 0.39
ACHE P22303 1/20 0.39
PRKAA2 P54646 1/20 0.38
ALDH1A1 P00352 1/20 0.38
ALOX15 P16050 1/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27637814 0.88 MEN1 (0.45) MEN1KMT2AKCNH2LMNAKCNA5
SCHEMBL27618696 0.88 MEN1 (0.45) MEN1KMT2AKCNH2LMNAKCNA5
SCHEMBL6514089 0.84 KCNH2 (0.44) MEN1KMT2AKCNH2LMNAKCNA5
SCHEMBL1762977 0.80 CYP2C9 (0.49) KMT2AKCNH2SIGMAR1KDM4EALDH1A1
SCHEMBL27637811 0.75 LMNA (0.52) MEN1KMT2AKCNH2LMNAKCNA5
SCHEMBL1763655 0.69 CYP2C19 (0.51) KMT2AKCNH2LMNAKDM4EALDH1A1
SCHEMBL30122294 0.69 CYP2D6 (0.56) MEN1KMT2AKCNH2LMNAKCNA5
SCHEMBL28168044 0.69 CYP2C9 (0.68) MEN1KMT2AKCNH2LMNAKCNA5
SCHEMBL1763425 0.69 CYP3A4 (0.60) KMT2AKCNH2SIGMAR1ALDH1A1
SCHEMBL2080255 0.68 CYP3A4 (0.55) KMT2AKCNH2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101229164-B Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives BRISTOL MYERS SQUIBB CO 2013-01-02 CN disclosed
CN-101229164-A Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives BRISTOL MYERS SQUIBB CO (US) 2008-07-30 CN disclosed
CN-100379421-C Compositions and antiviral activity of substituted azaindoloxoacetylpiperazine derivatives BRISTOL MYERS SQUIBB CO (US) 2008-04-09 CN disclosed
CN-1688311-A Compositions and antiviral activity of substituted azaindoloxoacetylpiperazine derivatives BRISTOL MYERS SQUIBB CO (US) 2005-10-26 CN disclosed